You are here

Adolesanda obezite ve tip 2 diabetes mellitus

Obesity and type 2 diabetes mellitus in adolescents

Journal Name:

Publication Year:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Obesity became a global epidemic. Similarly, the global prevalance of childhood and adolescent obesity dramatically increased after the 1990s. A number of consequences of childhood and adolescent obesity are seen in this period and later in life. These problems are dyslipidaemia, hypertension, cardiac abnormalities, endothelial dys¬function, fatty liver disease, hyperinsulinemia, insuline resistance, type 2 diabetes, psychological problems, pubertal disorders, and economic burden. Obesity is one of the most important risk factor for developing type 2 diabetes in adolescents as in addition to genetic and ethnic factors. Therefore the prevention of adolescent obesity and type 2 diabetes is an important task of pediatricians.
Abstract (Original Language): 
Obezite global epidemik bir problem haline gelmiştir. Benzer şekilde 1990 yıllarından itibaren çocukluk ve adolesan obezite pre-valansmda da dramatik artışlar yaşanmaktadır. Çocukluk ve ado-lesan obezitesinin bir dizi sonuçları vardır. Bunlar arasında dislipi-demi, hipertansiyon, kardiak sorunlar, endotelial disfonksiyon, karaciğer yağlanması, hiperinsülinemi, insülin direnci, tip 2 diabet, psikolojik sorunlar, pubertal sorunlar ve ekonomik yük sayılabilir. Adolesan tip 2 diabet oluşumunda genetik ve ırka bağlı faktörlere ek olarak en önemli etken obezite varlığıdır. Bu nedenle obezite ve tip 2 diabetin önlenmesinde pediatristlere önemli görevler düş¬mektedir.

REFERENCES

References: 

1.
Arslanoğl
u İ. Çocukve ergenlerde şişmanlıksorunu ve yaklaşım. Türk Pediatri Arşivi 2009;44:115-9.
2. Skelton JA, Cook SR, Auinger P, Klein JD, Barlw SE. Prevalance and trends of severe obesity among US children and adolescents. Acad Pediatr 2009;9:
322-9.
3.
Semi
z S, Özdemir ÖMA, Özdemir AS. Denizli merkezinde 6-15 yaş grubu çocuklarda obezite sıklığı. Pamukkale Üniversitesi Tıp Dergisi 2008;1:1-4.
4.
Oztur
k A, Mazicioglu MM, Hatipoglu N, Budak N, Keskin G, Yazlak Z, Balci N, Yildiz H, Yildiz K, Ustunbas HB, Kurtoglu S. Reference body mass index curves for Turkish children 6 to 18 years of age. J Pediatr Endocrinol Metab 2008;21:827-36.
5. Yuca SA,
Yılma
z C, Cesur Y, Doğan M, Kaya A, Başaranoğlu M. Prevalance of overweight and obesity in children and adolescents in Eastern Turkey. J Clin Res Pediatr Endocrinol 2010;2:159-63.
6. Simsek E, Akpınar S, Bahcebası T, Sense DA, Kocabay K. The prevalance of overweight and obese children aged 6-17 years in the West Black Sea
region of Turkey. Int J Clin Pract 2008;62:1033-8.
7. Kutlu R, Çivi S, Karaoğlu O. Can waist circumference clinically be useful as a predictor of obesity/underweight in children? Gülhane Tıp Dergisi
2011;53:170-6.
8. Etiler N, Cizmecioglu FM, Hatun S, Hamzaoglu O. Nutritional status of students in Kocaeli, Turkey: a population-based study. Pediatr Int 2011;53:
231-5.
9. Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed 2011;96:378-82.
10. Glass AR. Endocrine aspects of obesity. Med Clin N Am1989;73:139-60.
11. Barlow SE and the Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120:S164-S192.
12. Böttcher Y, Körner A, Kovacs P, Kiess W. Obesity genes: implication in childhood obesity. Paediatr Child Health 2012;22:31-6.
13. Tang-Peronard JL, Andersen HR, Jensen TK, Heitmann BL. Endocrine-disrupting chemicals and obesity development in humans: a review. Obes Rev 2011;12:622-636.
14. Lambourne K, Donnelly JE. The role of physical activity in pediatric obesi¬ty. Pediatr Clin North Am2011;58:1481-91.
15. Ozturk A, Mazıcıoglu MM, Poyrazoglu S, Cicek B, Gunay O, Kurtoglu S. The relationship between sleep duration and obesity in Turkish children and
adolescents. Acta Paediatr 2008;98:699-702.
16. Pardee PE, Norman GJ, Lustig RH, Preud'homme D, Schwimmer JB. Television viewing and hypertension in obese children. Am J Prev Med2007;
33:439-43.
17. Zhou J, Cerny V, Lehmann C. Fructose-the sweet poison. J Parent Enter
Nutr2011;35:158-9.
18. Garipagaoglu M, Budak N, Süt N, Akdimken Ö, Oner N, Bundak R. Obesity risk factors in Turkish children. J Pediatr Nurs2008;24:332-7.
19. Ng KC, Lai SW. Application of anthropometric indices in childhood obesi¬ty. South Med J2004;97:566-70.
20. Freedman DS, Khan LK, Serdula MK, Dietz WH, Sirinivasan SR,
Berenson GS. Interrelationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Hearth Study. Int J Obes Relat Metab Disord
2004;28:10-6.
21. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatrica 2006;95:194-8.
22. Karasalihoglu S, Öner N, Ekuklu G, Vatansever Ü, Pala Ö. Body mass index percentiles among adolescent girls living in Edirne Turkey. Pediatr Int
2003;45:452-7.
23. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a Standard for child overweight and obesity worldwide: international study. Br Med J2000;
320:1-6.
24. deMoraes ACF, Fadoni RP, Ricardi LM, et al. Prevalance of abdominal obe¬sity in adolescents: a systematic review. Obes Rev 2011;12: 69-77.
25. Hatipoglu N, Ozturk A, Mazıcıoglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7-to 17-year-old Turkish children and
adolescents. Eur J Pediatr2008;167:383-9.
26.
Mazıcıogl
u MM, Hatipoğlu N, Öztürk A, Çiçek B, Üsttünbaş HB, Kurtoğlu S. Waist circumference and mid-upper arm circumference in evaluation of obesity in children aged between 6 and 17 years. J Clin Res Pediatr
Endocrinol2010;2:144-50.
27. Hatipoglu N, Mazicioglu MM, Kurtoglu S, Kendirci M. Neck circumfer¬ence: an additional tool of screening overweight and obesity in childhood.
Eur J Pediatr2010;169:733-9.
28. Mazicioglu MM, Kurtoglu S, Ozturk A, Hatipoglu N, Cicek B, Ustunbas HB. Percentiles and mean values for neck circumference in Turkish children
aged 6-18 years. Acta Paediatr2010;99:1847-53.
29. Kurtoglu S, Mazicioglu MM, Ozturk A, Hatipoglu N, Cicek B, Ustunbas HB. Body fat reference curves for healthy Turkish children and adolescents.
Eur J Pediatr2010;169:1329-35.
30. Olson ML, Maalouf NM, Oden JD, WEhite PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J
Clin Endocrinol Metab 2012;97:279-85.
31. Kotlyarevska K, Wolfgram P, Lee JM. Is waist circumference a beter pre¬dictor of insulin resistance than body mass index in US adolescents. J Adolesc
Health 2011;49:330-3.
32. Charchman RM, Dechert-Zeger M, Calıkoglu AS, Haris BD. A new chal¬lenge in pediatric obesity: pediatric hyperglycemic hyperosmolar coma.
Pediatr Crit Care Med 2005;6:20-4.
S42
Kurtoğlu S| Adolesanda obezite ve tip 2 diabetes mellitus
33. Cook S, Kavey REW. Dyslipidemia and pediatric obesity. Pediatr Clin N
Am2011;58:1363-73.
34. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazıcı C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics2005;115:500-3.
35. Mazicioglu MM, Yalcın MB, Ozturk A, Hatipoglu N, Ustunbas HB, Kurtoglu S. Anthropometric risk factors for elevated blood pressure in ado¬lescents in Turkey aged 11-17. Pediatr Nephrol2010;25:2327-34.
36. Zimmet P, Alberti K, George MM, et al; Concensusu Group. The metabolic syndrome in children and adolescents- an IDF concensusu report. Pediatr
Diab 2007;8:299-306.
37. Hatipoğlu N, Akın L, Kurtoğlu S. Therapeutic approach to obesity in chil¬dren and adolescents. J Clin Res Pediatr Endocrinol 2009;1(suppl 1):72-8.
38. Steinbeck K. Adolescents overweight and obesity. How the best to manage in the general practice setting. Austr Fam Phys2007;36:606-11.
39. Greydanus DE, Bricker LA, Feucht C. Pharmacotherapy for obese adoles¬cents. Pediatr Clin N Am 2011;58:139-53.
40. Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to convention¬al treatment in adolescents with severe obesity. Eur J Pediatr 2004;163:738-
41.
41. Atabek ME, Pirgon O. Use of metformin in obese adolescents with hyper-insulinemia: a 6 month, randomized, double blind, placebo controlled clini¬cal trial. J Pediatr Endocrinol Metab 2008;21:339-48.
42. Zeitler P. Considerations regarding the diagnosis and treatment of child¬hood type 2 diabetes. Postgrad Med 2010;122: 89-97.
43. Mohamadi A, Cooke DW. Type 2 diabetes mellitus in children and adoles¬cents. Adolesc Med2010;21:103-19.
44. Goran MI, Davis J, Kelly L ,Shaibi G, Spruijt-Metz D, Soni SM,
Weigensberg M. Low prevalance of pediatric type 2 diabetes: where's the
epidemic? J Pediatr2008;152:753-5.
45. Pinnas-Hamiel O, Zeitler P. The global spread of type 2 diabetes in children
and adolescents. J Pediatr 2005;146:693-700.
46. Reinehr T. Clinical presentation of type 2 diabetes mellitus in children and
adolescents. Int J Obes (Lond)2005;29(suppl 2):S105-S110.
47. Fagot-Campagna A, Pettitt DJ, Engelgau MM et al .Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr2000;136:664-72.
48. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler
PS. The type 2 family: a setting for development and treatment of adoles¬cent type 2 diabetes mellitus. Arch Pediatr Adolesc Med1999;153:1063-7.
49. Liese AD, D'Agostino RBJr, Hamman RF, et al. The burden of diabetes mellitus among US youth: prevalance estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510-1518.
50. Grant RW, Moore AF, Florez JC. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care 2009;32:1107-14.
51. Type 2 diabetes in children and adolescents. American Diabetes Association.
Diabetes Care2000;23:381-9.
52. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 Diabetes in children and adolescents. Pediatr Diabetes2009;10(suppl
12):17-32.
53. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ;
ISPAD. ISPAD Clinical Practice Concensus Guidelines 2006-2007. Type
2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 2008;9:
512-26.
54. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson C, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J
Clin Endocrinol Metab 2008;93:4231-7.
55. Bloomgarden ZT. A1C: recommendations, debates, and questions. Diabetes
Care 2009;32:141-7.
56. American Diabetes Association. Diagnosis and classification of diabetes mel-litus. Diabetes Care 2010;33(suppl 1):S62-S69.
57. Wales JK. Evaluation of growth disorders. In: Brook C, Clayton P, Brown R, editors. Brook's Clinical Pediatric Endocrinology. Edinburgh: Wiley-
Blackwell; 2009. p. 124-54.
58. Vaxillaire M, Froguel P. Monogenic diabetes in the young, pharmcogenet-ics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 2008;
29:254-64.
59. Renehr T, Schober E, Wiegand S, Thon A, Holl R. Beta-cell autoantibod-ies in children with type 2 diabetes mellitus: subgroup or misclassification?
Arch Dis Child2006;91:473-7.
60. Schwartz MS, Chadha A. Type 2 diabetes mellitus in childhood: obesity and
insulin resistance. JAOA2008;108:518-24.
61. Chiu HK, Tsai J, Junuja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP. Equivalent insulin resistance in latent autoimmun dia, in adults (LADA) and type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:237-44.
62. Service FJ, Rizza RA, Zimmerman DBR, Dyck PJ, O'Brien PL, Melton LJ.
The classification of diabetes by clinical and C-peptide criteria. A prospec¬tive population-based study. Diabetes Care 1997;20:198-201.
63. Kaufman FR. Type 2 diabetes in children and youth. Endocrinol Metab Clin
N Am 2005;34:659-76.
64. Ludvigsson L, Carlsson A, Forsander G, Ivarsson S, Kockum I, Lendmark A, Lindblad B, Marcus C, Samuelsen U. C-peptide in the classification of diabetes in children and adolescents. Pediatric Diabetes 2012;13:45-50.
65. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997;20:
484-6.
66. Jones KL, Arslanian P, Peterokova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: a randomized con¬trolled trial. Diabetes Care2002;25:89-94.
67. Gottschalk M, Dane T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, sin¬gle-blind comparative study. Diabetes Care 2007;30:790-4.
68. Malloy J, Capparelli E, Gottschhalk M, Guan X, Kothare P, Fineman M. Pharmacology and tolerability of a single dose exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a ran¬domized, placebo-controlled, single-blind, dose-escalation, crossover study.
Clin Ther2009;31:806-15.
69. Zeitler P, Epstein L, Grey M, Hirst K, Kaufman F, Tamborlane W, Wilfley D. TODAY Study Group. Treatment options for type 2 diabetes in adoles¬cents and yoth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007;8:74-87.
70. Chiasson J, Josse R, Hunt J, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM. The efficacy of acarbose in the treatment of patients with non-insulin dependent diabetes mellitus: a multicenter con¬trolled clinical trial. Ann Intern Med1994;121:928-35.

Thank you for copying data from http://www.arastirmax.com